García-Carracedo, D., Villaronga, M. Á., Álvarez-Teijeiro, S., Hermida-Prado, F., Santamaría, I., Allonca, E., . . . García-Pedrero, J. M. (2016). Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas. Oncotarget.
Chicago Style CitationGarcía-Carracedo, Darío, et al. "Impact of PI3K/AKT/mTOR Pathway Activation On the Prognosis of Patients With Head and Neck Squamous Cell Carcinomas." Oncotarget 2016.
Cita MLAGarcía-Carracedo, Darío, et al. "Impact of PI3K/AKT/mTOR Pathway Activation On the Prognosis of Patients With Head and Neck Squamous Cell Carcinomas." Oncotarget 2016.
Atenció: Aquestes cites poden no estar 100% correctes.